Framework for Rational Donor Selection in Fecal Microbiota Transplant Clinical Trials

Fecal Microbiota Transplant (FMT) is gaining traction as a potentially effect treatment of the increasing number of diseases that have been linked to microbiome dysbiosis.

Mapping Human Microbiome Drug Metabolism by Gut Bacteria and Their Genes

In a recent study published in Nature by Zimmerman (et.al), researchers begin to uncover how intestinal bacteria chemically modify prescription drugs.

Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy

CMIT is collaborating with Dr. Patricia Pringle and Dr. Raymond Chung from Massachusetts General Hospital (MGH) on a new study that is investigating the potential role of fecal microbiota transplantation (FMT) as a treatment for hepatic encephalopathy.